On 5-6 February 2019, international life sciences investors, C-level executives, and industry stakeholders will gather in London for the 5th annual LSX World Congress.
The two-day event will see leaders from across the sector take to the stage to discuss financing, partnering, development and commercialisation strategies, identify emerging trends, and share case studies.
Panel discussions will explore a range of issues shaping the future of the industry, such as the impact of non-traditional entrants on the medtech innovation system, which will be debated by Bruce Culleton, VP and CMO, Kidney Care at CVS Health, Martin Pfister, Senior Investment Manager at High-Tech Gründerfonds, Nissim Darvish, Senior Managing Director at Orbimed, and John Milad, CEO at Quanta Dialysis Technologies. Meanwhile, as emerging technologies and the data underpinning such technologies gear up to play an increasingly prominent role in the healthcare landscape, Martha Carruthers, Head of Life Science Partnerships at Medopad, Manish Marotkar, Head of Business Development at Siemens Healthineers Digital Ecosystem, and Hugh Lloyd-Jukes, CEO at Oxehealth, will examine the opportunities and challenges this brings.
In the biotech stream, Jørgen Drejer, CEO at Saniona, Harpreet Singh, CEO at Immatics Biotechnologies, Nathalie Ter Wengel, European Head, Worldwide Business Development at Pfizer, and Ajan Reginald, CEO at Celixir, will discuss strategic partnerships for progressing assets through the clinic, while investors Laia Crespo, Head of Europe at Sanofi Ventures, Thierry Laugel, Managing Partner at Kurma Partners, Peter Finan, Partner at Epidarex Capital, and Bart Van Hooland, Founding Partner at DROIA, will talk through the latest developments at their firms.
Heather Wasserman, Vice President at Eli Lilly, Sarah Cole, Partner at Takeda Ventures, Hakan Goker, Senior Investment Director at M Ventures, and Fiona de Hemptinne, Partner at UCB Ventures, will talk through corporate venture models and strategies, and Josh Richardson, Managing Director at Longitude Capital, Dominic Schmidt, Partner at Syncona, Patrik Sobocki, Investment Manager at Industrifonden, and Patrick Van Beneden, Partner at Gimv, will discuss the biotech growth finance environment.
In addition to the main conference streams, the event will feature one-to-one partnering and networking opportunities, company showcases spanning biotech, medtech and healthtech, and an innovation zone that will shine a spotlight on technologies coming out of Europe’s leading academic and research and development institutions. Satellite sessions include a public CEO forum, private CEO forum, start-up CEO forum, pharma BD leaders forum, commercial leaders BD forum, M&A workshop, licensing and collaboration workshop, and IPO bootcamp.
The event will take place on 5-6 February at etc.venues, St Paul’s, London. Find out more.
Feature image © lisakolbasa – stock.adobe.com